News

HistoSonics, the manufacturer of the Edison® Histotripsy System and novel histotripsy therapy platforms, announced today that Addenbrookes Hospital of ...
Doctors and researchers are exploring various approaches to tackle this pervasive health issue, from new medications to dietary interventions. But what if one of the most promising treatments relies ...
Breast cancer is a malignant tumor that occurs in mammary gland tissue. It is the most common cancer in women in Korea, and ...
Scientists developed nanoparticles that respond to warmth inside tumors to boost ultrasound clarity, offering a safer and ...
HistoSonics has completed patient enrollment in a pivitol clinical trial to evaluate its Edison histotripsy system in ...
The future of non-invasive cancer therapy is bright. Liver tumors can now be destroyed—without radiation, chemotherapy or surgery—thanks to new medical technology known as histotripsy.
The Edison system was one of just eight available application spots for the U.K. market in 2024, HistoSonics said.
Virginia Tech researchers are developing more precise treatments for pediatric brain cancer using a new class of therapies ...
After FDA approval in late 2023, the non-invasive liver tumor treatment histotripsy has been used at University of Michigan ...
Medical imaging scans that create detailed images of the body’s internal structures are widely used in medicine. Doctors need ...
The 'Bachelorette' alum shared an update in her ongoing breast cancer struggle as she's "trying to live my best life as a ...
Corewell Health has recently acquired a new tool to help treat patients with certain liver cancers, and the first treatments ...